Role of genetic algorithms and artificial neural networks in predicting the phase behavior of colloidal delivery systems

Agatonovic-Kustrin, S; Alany, RG

HERO ID

4683799

Reference Type

Journal Article

Year

2001

Language

English

PMID

11496944

HERO ID 4683799
In Press No
Year 2001
Title Role of genetic algorithms and artificial neural networks in predicting the phase behavior of colloidal delivery systems
Authors Agatonovic-Kustrin, S; Alany, RG
Journal Pharmaceutical Research
Volume 18
Issue 7
Page Numbers 1049-1055
Abstract <strong>PURPOSE: </strong>A genetic neural network (GNN) model was developed to predict the phase behavior of microemulsion (ME), lamellar liquid crystal (LC), and coarse emulsion forming systems (W/O EM and O/W EM) depending on the content of separate components in the system and cosurfactant nature.<br /><br /><strong>METHOD: </strong>Eight pseudoternary phase triangles, containing ethyl oleate as the oil component and a mixture of two nonionic surfactants and n-alcohol or 1,2-alkanediol as a cosurfactant, were constructed and used for training, testing, and validation purposes. A total of 21 molecular descriptors were calculated for each cosurfactant. A genetic algorithm was used to select important molecular descriptors, and a supervised artificial neural network with two hidden layers was used to correlate selected descriptors and the weight ratio of components in the system with the observed phase behavior.<br /><br /><strong>RESULTS: </strong>The results proved the dominant role of the chemical composition, hydrophile-lipophile balance, length of hydrocarbon chain, molecular volume, and hydrocarbon volume of cosurfactant. The best GNN model, with 14 inputs and two hidden layers with 14 and 9 neurons, predicted the phase behavior for a new set of cosurfactants with 82.2% accuracy for ME, 87.5% for LC, 83.3% for the O/W EM, and 91.5% for the W/O EM region.<br /><br /><strong>CONCLUSIONS: </strong>This type of methodology can be applied in the evaluation of the cosurfactants for pharmaceutical formulations to minimize experimental effort.
Pmid 11496944
Is Certified Translation No
Dupe Override No
Is Public Yes
Language Text English